“Few have been discussing the fact that last year’s health care law will increase gross federal debt and thus accelerate the speed at which we will approach the statutory debt limit in the future. As elected officials wrestle with these two contentious issues (health care and the debt limit) it seems reasonable to set a minimum policy goal that last year’s health care law be modified so that it at least not worsen the statutory debt outlook.”

“These taxes and fees are less important than the implications of the law’s gargantuan reordering of the pharmaceutical marketplace. Over the long term, Obamacare will cause a significant degradation of the private-sector market for pharmaceuticals, a market that has been the best in the world.”